The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
After finishing at $0.81 in the prior trading day, Applied Dna Sciences Inc (NASDAQ: APDN) closed at $0.67, down -17.28%. In other words, the price has decreased by -$17.28 from its previous closing price. On the day, 1.27 million shares were traded.
Ratios:
Our goal is to gain a better understanding of APDN by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.27 and its Current Ratio is at 4.45. In the meantime, Its Debt-to-Equity ratio is 0.04 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, ROTH Capital on February 12, 2021, initiated with a Buy rating and assigned the stock a target price of $24.
On January 14, 2021, H.C. Wainwright reiterated its Buy rating and also upped its target price recommendation from $18 to $14.
H.C. Wainwright reiterated its Buy rating for the stock on December 18, 2020, while the target price for the stock was revised from $20 to $12.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 1.15 while its Price-to-Book (P/B) ratio in mrq is 0.41.
Stock Price History:
Over the past 52 weeks, APDN has reached a high of $177.00, while it has fallen to a 52-week low of $0.72. The 50-Day Moving Average of the stock is -59.34%, while the 200-Day Moving Average is calculated to be -96.43%.
Shares Statistics:
A total of 6.50M shares are outstanding, with a floating share count of 6.42M. Insiders hold about 1.16% of the company’s shares, while institutions hold 9.27% stake in the company.
